Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10025415HBVENSG00000257335.8protein_codingMGAMYesNo8972E7ER45
O43451
TVIS30080980HIVENSG00000257335.8protein_codingMGAMYesNo8972E7ER45
O43451
TVIS20062222HPVENSG00000257335.8protein_codingMGAMYesNo8972E7ER45
O43451
TVIS20031824HPVENSG00000257335.8protein_codingMGAMYesNo8972E7ER45
O43451
TVIS44022679HTLV-1ENSG00000257335.8protein_codingMGAMYesNo8972E7ER45
O43451
TCGA Plot Options
Drug Information
GeneMGAM
DrugBank IDDB00284
Drug NameAcarbose
Target IDBE0000837
UniProt IDO43451
Regulation Typeinhibitor
PubMed IDs16702880; 19275550; 8893066
CitationsZhang H, Kallwass H, Young SP, Carr C, Dai J, Kishnani PS, Millington DS, Keutzer J, Chen YT, Bali D: Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease. Genet Med. 2006 May;8(5):302-6.@@Yamagishi S, Matsui T, Ueda S, Fukami K, Okuda S: Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disorders. Curr Drug Metab. 2009 Feb;10(2):159-63.@@Martin AE, Montgomery PA: Acarbose: an alpha-glucosidase inhibitor. Am J Health Syst Pharm. 1996 Oct 1;53(19):2277-90; quiz 2336-7. doi: 10.1093/ajhp/53.19.2277.
GroupsApproved; Investigational
Direct ClassificationAminocyclitol glycosides
SMILES[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO
Pathways
PharmGKBPA448010
ChEMBLCHEMBL1566